Dis-Chem Reports R23 Billion Revenue in Half-Year Results

On 29 October, Dis-Chem Pharmacies released interim results for the six months ended 31 August 2026, reporting group revenue of R23.0 billion, an increase of 8.0% from R21.3 billion in the previous comparable period. Earnings per share were 64.1 cents, compared with 73.9 cents a year earlier. These are company-wide financial results, not a new healthcare project contract. Pharmacy groups, hospitals and healthcare providers can explore opportunities in patient-data management, inventory forecasting and operational analytics. HPC can support healthcare data platforms and business-intelligence systems; contact HPC for a quotation based on the confirmed technical requirements.